Wednesday, June 22, 2022

STEVE appears from blood-red arc of light in New Zealand footage

Must read

STEVE appears from blood-red arc of light in New Zealand footage

On March 17, 2015, a blood-red arc of light cut through the sky hundreds of miles above New Zealand. Over the next half hour,...

UK & US Deals For Horror Comedy’The Leech’ — Global Briefs – Deadline

Arrow Strikes For UK & US Rights To Horror Pic'The Leech' EXCLUSIVE: Arrow Films has acquired rights in the UK, Ireland, US and Canada to...

On March 17, 2015, a blood-red arc of light cut through the sky hundreds of miles above New Zealand. Over the next half hour, an amateur skywatcher observed that arc as it transformed before his eyes into one of Earth’s most puzzling atmospheric mysteries. — The eerie ribbon of light known as STEVE — newly released images reveal.

STEVE, short for “strong thermal velocity enhancement,” is an atmospheric oddity first described in 2018, after amateur aurora chasers saw a narrow stream of gauzy purple light arc across the sky over northern Canada. Scientists who studied the phenomenon soon confirmed that STEVE was not an an aurora — The multi-colored glow that appears at high latitudes when solar particles collide with atoms high in Earth’s atmosphere. Rather, STEVE was a separate and unique phenomenon that’s “completely unknown“to science.

- Advertisement -

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest article

STEVE appears from blood-red arc of light in New Zealand footage

On March 17, 2015, a blood-red arc of light cut through the sky hundreds of miles above New Zealand. Over the next half hour,...

UK & US Deals For Horror Comedy’The Leech’ — Global Briefs – Deadline

Arrow Strikes For UK & US Rights To Horror Pic'The Leech' EXCLUSIVE: Arrow Films has acquired rights in the UK, Ireland, US and Canada to...

FluGen Announces First Subject Dosed in Phase 1b Clinical Trial of its Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults

– Study will measure immune responses generated by M2SR and high dose vaccine separately and in combination in the highly vulnerable 65-85 years old...